GenScript Received OLAW (Office of Laboratory Animal Welfare) Approval for Animal Welfare Assurance
GenScript received the approval of Animal Welfare Assurance for its animal facility on 9 Nov, 2010. This approval accentuates the responsibilities and procedures of GenScript regarding the care and use of laboratory animals.
- (1888PressRelease) November 22, 2010 - PISCATAWAY, N.J - Internationally recognized biology contract research organization GenScript USA Inc. received the approval of Animal Welfare Assurance from the Office of Laboratory Animal Welfare (OLAW) of the U.S. National Institutes of Health (NIH) for its animal facility on 9 Nov, 2010. This Assurance is effective until 30 Nov 2015.
GenScript is constantly dedicated to the welfare of laboratory animals. The animal facility of GenScript is AAALAC International accredited since 2009. The approval of Animal Welfare Assurance accentuates the responsibilities and procedures of GenScript regarding the care and use of laboratory animals.
"This credential will greatly facilitate the antibody and animal services to our customers," commented Dr. Nick YAN, Vice President of GenScript. "Our purpose of having Animal Welfare Assurance is to reinforce our principle on laboratory animal welfare, so that we can provide quality services to our clients," commented Mr. Liang CAO, Manager of Animal Model Department.
The OLAW provides guidance and interpretation of the Public Health Service (PHS) Policy on Humane Care and Use of Laboratory Animals.
GenScript is a contract research organization (CRO) specialized in biological research and early-phase drug discovery services. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development. The renowned one-stop bioreagent services include custom gene synthesis and molecular biology, custom protein expression and purification, custom peptide synthesis, antibody production, and custom cell line development. Headquartered in Piscataway, New Jersey, GenScript is the largest gene synthesis supplier in the USA, with subsidiaries in France, Japan, and China.
For further information, please contact:
Executive Vice President
GENSCRIPT USA Inc.
Your Innovation Partner in Drug Discovery!